ChartRow logo
Data provided bySource: Twelve Data
SMMT
$10.67-9.73%
as of close, Nov 17, 2026
☾ AH $10.67 -9.73%
PeersBBIOBNTXASNDARGXGHPRAX
Share this page

Summit Therapeutics Inc. Common Stock trailing returns

Summit Therapeutics Inc. Common Stock's 10-year return is +0.2% a year (CAGR) (+1.6% cumulative). How Summit Therapeutics Inc. Common Stock (SMMT) has performed over the last day, week, month and year, over 5 and 10 years, and since inception, through November 17, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

Data provided bySource: Twelve Data

To 2026-11-17. Price return + dividends = total return. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
Cumulative
1 day-9.7%+0.0%-9.7%—
5 days-40.2%+0.0%-40.2%-40.2%Nov 17
1 month-27.1%+0.0%-27.1%-40.2%Nov 17
YTD-39.0%+0.0%-39.0%-59.6%Nov 17
Per year (CAGR)
1 year-37.1%+0.0%-37.1% CAGR-59.6%Nov 2026
5 years+14.5%+0.0%+14.5% CAGR+97.2% total-87.6%Dec 2022
10 years+0.2%+0.0%+0.2% CAGR+1.6% total-95.8%Dec 2022
Since 2015+0.4%+0.0%+0.4% CAGR+4.7% total-95.8%Dec 2022

Growth of SMMT#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years+14.5%/year · +97.2%
  • 10 years+0.2%/year · +1.6%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-11-17). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in SMMT's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Summit Therapeutics Inc. Common Stock's 10-year return?
Over the last 10 years, Summit Therapeutics Inc. Common Stock (SMMT) returned about +0.2% a year annualized (+1.6% cumulative total return).
What is Summit Therapeutics Inc. Common Stock's return since inception?
Since 2015, Summit Therapeutics Inc. Common Stock (SMMT) has compounded at about +0.4% a year — +4.7% in total.

More on Summit Therapeutics Inc. Common Stock